These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25257072)

  • 21. Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis.
    Mol MJ; Stalenhoef AF
    Neth J Med; 1990 Jun; 36(5-6):279-87. PubMed ID: 2395495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial hypercholesterolaemia: clinical features and management.
    Pottle A
    Nurs Stand; 2005 Dec 14-2006 Jan 3; 20(14-16):55-65; quiz 66. PubMed ID: 16372559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Selection criteria for treatment of severe hyperlipoproteinemias with LDL apheresis].
    Bláha V; Zadák Z; Bláha M; Havel E; Solichová D; Brátová M; Malý J; Kmonícek L
    Cas Lek Cesk; 1998 Jul; 137(14):424-9. PubMed ID: 9748737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biological efficacy of LDL apheresis in major hypercholesterolemia].
    Dairou F; Assogba U; Bruckert E; De Gennes JL; Turpin G
    Ann Med Interne (Paris); 1994; 145(5):328-32. PubMed ID: 7985942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
    Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression of atherosclerosis in patients with familial hypercholesterolaemia under LDL-apheresis.
    Borberg H; Gaczkowski A; Hombach V; Oette K; Stoffel W
    Prog Clin Biol Res; 1988; 255():317-26. PubMed ID: 3340643
    [No Abstract]   [Full Text] [Related]  

  • 27. [Apheresis in severe hypercholesterolaemia].
    Graesdal A; Hovland A; Bjørbaek E
    Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1085-7. PubMed ID: 15114383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management in familial hypercholesterolaemia in children and adolescents. Position of the Lipid Expert Forum].
    Myśliwiec M; Walczak M; Małecka-Tendera E; Dobrzańska A; Cybulska B; Filipiak KJ; Mazur A; Jarosz-Chobot P; Szadkowska A; Rynkiewicz A; Chybicka A; Socha P; Brandt A; Kubalska J; Bautembach-Minkowska J; Limon J; Zdrojewski T; Limon J; Banach M;
    Kardiol Pol; 2013; 71(10):1099-105. PubMed ID: 24197602
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of homozygous familial hypercholesterolaemia.
    Sharma SK; Kaushal R; Chattopadhyay TK
    Br Med J (Clin Res Ed); 1985 Dec; 291(6509):1644. PubMed ID: 3935218
    [No Abstract]   [Full Text] [Related]  

  • 30. Extracorporeal plasma therapy for homozygous familial hypercholesterolaemia.
    Graisely B; Cloarec M; Salmon S; Polonovski J; Polonovski C; Delacotte JM; Cavalier J; Vergoz D; Salmon C
    Lancet; 1980 Nov; 2(8204):1147. PubMed ID: 6107765
    [No Abstract]   [Full Text] [Related]  

  • 31. [The apheresis of low-density lipoproteins in homozygous familial hypercholesterolemia].
    Ros Rahola E
    Med Clin (Barc); 1993 Jan; 100(3):117-8. PubMed ID: 8426494
    [No Abstract]   [Full Text] [Related]  

  • 32. Familial hypercholesterolemia: current treatment options and patient selection for low-density lipoprotein apheresis.
    Hemphill LC
    J Clin Lipidol; 2010; 4(5):346-9. PubMed ID: 21122676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy criteria and cholesterol targets for LDL apheresis.
    Thompson GR; Barbir M; Davies D; Dobral P; Gesinde M; Livingston M; Mandry P; Marais AD; Matthews S; Neuwirth C; Pottle A; le Roux C; Scullard D; Tyler C; Watkins S
    Atherosclerosis; 2010 Feb; 208(2):317-21. PubMed ID: 19589528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lomitapide for homozygous familial hypercholesterolaemia.
    Raal FJ
    Lancet; 2013 Jan; 381(9860):7-8. PubMed ID: 23122767
    [No Abstract]   [Full Text] [Related]  

  • 35. [LDL apheresis--an effective treatment of homozygous familial hypercholesterolemia].
    Kauppinen-Mäkelin R; Koivisto V; Virtanen KS; Taskinen MR; Miettinen T
    Duodecim; 1990; 106(21):1465-70. PubMed ID: 1364677
    [No Abstract]   [Full Text] [Related]  

  • 36. [LDL-apheresis: current status].
    Stefanutti C; Vivenzio A; Lucani G; Di Giacomo S
    Clin Ter; 2001; 152(1):65-9. PubMed ID: 11382172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for the diagnosis and management of familial hypercholesterolaemia.
    Sullivan D;
    Heart Lung Circ; 2007 Feb; 16(1):25-7. PubMed ID: 17188936
    [No Abstract]   [Full Text] [Related]  

  • 38. LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia.
    Nenseter MS; Bogsrud MP; Græsdal A; Narverud I; Halvorsen B; Ose L; Aukrust P; Holven KB
    Thromb Res; 2012 Nov; 130(5):823-5. PubMed ID: 22728023
    [No Abstract]   [Full Text] [Related]  

  • 39. [LDL-apheresis in the treatment of familial hypercholesterolemia].
    Scarpato N; Postiglione A
    Ric Clin Lab; 1985; 15 Suppl 1():499-504. PubMed ID: 4035229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
    Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
    Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.